Basso Capital Management’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Basso Capital Management’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-87,325	Closed	-$872K	–	366
2022 Q3	$872K	Sell	87,325 -25,005	-22%	-$248K	0.21%	145
2022 Q2	$1.11M	Sell	112,330 -1,980	-2%	-$19.5K	0.12%	271
2022 Q1	$1.13M	Hold	114,310	–	–	0.11%	287
2021 Q4	$1.11M	Hold	114,310	–	–	0.12%	242
2021 Q3	$1.12M	Buy	114,310 +12,210	+12%	+$118K	0.13%	224
2021 Q2	$988K	Buy	102,100 +50,000	+96%	+$487K	0.13%	231
2021 Q1	$503K	Buy	+52,100	New	+$506K	0.08%	221

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Basso Capital Management's PKBO Position: Q4 2022 in Review

Basso Capital Management sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 87,325 shares — an estimated $872K sold.

Basso Capital Management first reported a position in PKBO in Q1 2021 and held it in 7 quarters. The position peaked at $1.13M in Q1 2022. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

Basso Capital Management reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Basso Capital Management sold 87,325 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $872K.
Basso Capital Management first reported a position in Peak Bio, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Basso Capital Management's Peak Bio, Inc. Common Stock position peaked at $1.13M in Q1 2022.
9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on Basso Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.